Oculoectodermal syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:3339OMIM:600268Q82.4
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Oculoectodermal syndrome (OES), also known as oculo-ectodermal syndrome or epidermal nevus syndrome with ocular involvement, is a rare congenital disorder characterized by the combination of epibulbar dermoids (benign growths on the surface of the eye) and aplasia cutis congenita (areas of absent skin, typically on the scalp). The condition primarily affects the eyes and skin (ectodermal tissues), and has been associated with activating mutations in the KRAS gene, occurring as a mosaic (postzygotic somatic) event rather than being inherited from a parent. Key clinical features include epibulbar or limbal dermoids, which are benign choristomas found on the eye surface that may affect vision, and areas of congenital skin deficiency most commonly located on the scalp. Additional features that have been reported in some patients include skin tags or accessory tragi (small skin appendages near the ears), coloboma of the eyelid, and occasionally other ectodermal abnormalities. Some patients may also present with pigmented skin lesions or organoid nevi. The severity and combination of features can vary considerably between affected individuals. There is no specific cure for oculoectodermal syndrome. Management is symptomatic and supportive, tailored to the individual's clinical manifestations. Surgical removal of epibulbar dermoids may be considered if they impair vision or for cosmetic reasons. Aplasia cutis congenita lesions on the scalp may require wound care and occasionally surgical repair. Regular ophthalmologic and dermatologic follow-up is recommended. Genetic counseling should be offered to affected families, though the condition typically arises sporadically due to somatic mosaicism.

Also known as:

Clinical phenotype terms— hover any for plain English:

Eyelid colobomaHP:0000625Abnormal conjunctiva morphologyHP:0000502Limbal dermoidHP:0001140Absent septum pellucidumHP:0001331Generalized hyperpigmentationHP:0007440Abnormal nervous system morphologyHP:0012639Abnormality of the earHP:0000598
Inheritance

Sporadic

Usually appears on its own, not inherited from a parent

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Oculoectodermal syndrome.

View clinical trials →

No actively recruiting trials found for Oculoectodermal syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Oculoectodermal syndrome community →

No specialists are currently listed for Oculoectodermal syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Oculoectodermal syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Oculoectodermal syndromeForum →

No community posts yet. Be the first to share your experience with Oculoectodermal syndrome.

Start the conversation →

Latest news about Oculoectodermal syndrome

No recent news articles for Oculoectodermal syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Oculoectodermal syndrome

What is Oculoectodermal syndrome?

Oculoectodermal syndrome (OES), also known as oculo-ectodermal syndrome or epidermal nevus syndrome with ocular involvement, is a rare congenital disorder characterized by the combination of epibulbar dermoids (benign growths on the surface of the eye) and aplasia cutis congenita (areas of absent skin, typically on the scalp). The condition primarily affects the eyes and skin (ectodermal tissues), and has been associated with activating mutations in the KRAS gene, occurring as a mosaic (postzygotic somatic) event rather than being inherited from a parent. Key clinical features include epibulb

How is Oculoectodermal syndrome inherited?

Oculoectodermal syndrome follows a sporadic inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Oculoectodermal syndrome typically begin?

Typical onset of Oculoectodermal syndrome is neonatal. Age of onset can vary across affected individuals.